“We anticipate operating cost reductions of nearly $1 billion in 2026 many AI enabled and importantly, in higher customer experience and satisfaction at a lower cost.”

In context

“ategic focus on margin recovery through product repositioning and repricing efforts enables us to estimate approximately 13% adjusted operating earnings growth across all of UHC. Principally from the improvement in serving commercial, and Medicare market needs. These actions should expand operating earnings margins for United by 40 basis points and are expected to result in membership contraction of 2.3 million to 2.8 million. The expected contraction in commercial membership is in line with our plans. While this will drive margin expansion in 2026, we still anticipate operating operating just slightly below our historical margin range until 2027. Our UHC recovery effort is being supported by steady efficiency gains as we advance AI and machine learning capabilities across our businesses. We anticipate operating cost reductions of nearly $1 billion in 2026 many AI enabled and importantly, in higher customer experience and satisfaction at a lower cost. Over 80% of calls from members leverage AI tools to help answer members' questions faster and more accurately. This enables our advocates to focus more time on a better service experience for individuals. Now I'll turn it over to Patrick Conway CEO of Optum. Patrick Conway: Thanks, Tim. And good morning, everyone. As we start 2026, Optum will be anchored around relentless focus on improved and consistent execution. In OptumHealth and OptumInsight. That will enable future margin expansion and top line growth. OptumRx will remain focused on maintaining its market position and providing a more comprehensive suite of pharmacy benefits and services. And continuing to pursue success in winning new customers for 2027 and 2028. All in highly competitive markets. Our 2026 performance outlook refle”